Cargando…

Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence

Inflammatory bowel disease (IBD) primarily describes two distinct chronic conditions with unknown etiology, ulcerative colitis (UC) and Crohn’s disease (CD). UC is limited to the colon, while CD may involve any portion of the gastrointestinal tract from mouth to anus. These diseases exhibit a patter...

Descripción completa

Detalles Bibliográficos
Autor principal: Misra, Sanghamitra M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928727/
https://www.ncbi.nlm.nih.gov/pubmed/27417473
http://dx.doi.org/10.3390/children1020149
_version_ 1782440480236109824
author Misra, Sanghamitra M.
author_facet Misra, Sanghamitra M.
author_sort Misra, Sanghamitra M.
collection PubMed
description Inflammatory bowel disease (IBD) primarily describes two distinct chronic conditions with unknown etiology, ulcerative colitis (UC) and Crohn’s disease (CD). UC is limited to the colon, while CD may involve any portion of the gastrointestinal tract from mouth to anus. These diseases exhibit a pattern of relapse and remission, and the disease processes are often painful and debilitating. Due to the chronic nature of IBD and the negative side effects of many of the conventional therapies, many patients and their families turn to complementary and alternative medicine (CAM) for symptom relief. This article focuses on the current available evidence behind CAM/integrative therapies for IBD.
format Online
Article
Text
id pubmed-4928727
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-49287272016-07-12 Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence Misra, Sanghamitra M. Children (Basel) Review Inflammatory bowel disease (IBD) primarily describes two distinct chronic conditions with unknown etiology, ulcerative colitis (UC) and Crohn’s disease (CD). UC is limited to the colon, while CD may involve any portion of the gastrointestinal tract from mouth to anus. These diseases exhibit a pattern of relapse and remission, and the disease processes are often painful and debilitating. Due to the chronic nature of IBD and the negative side effects of many of the conventional therapies, many patients and their families turn to complementary and alternative medicine (CAM) for symptom relief. This article focuses on the current available evidence behind CAM/integrative therapies for IBD. MDPI 2014-08-25 /pmc/articles/PMC4928727/ /pubmed/27417473 http://dx.doi.org/10.3390/children1020149 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Misra, Sanghamitra M.
Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence
title Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence
title_full Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence
title_fullStr Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence
title_full_unstemmed Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence
title_short Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence
title_sort integrative therapies and pediatric inflammatory bowel disease: the current evidence
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928727/
https://www.ncbi.nlm.nih.gov/pubmed/27417473
http://dx.doi.org/10.3390/children1020149
work_keys_str_mv AT misrasanghamitram integrativetherapiesandpediatricinflammatoryboweldiseasethecurrentevidence